Metropolitan Life Insurance Company (MetLife)’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,035
Closed -$15.6K 2479
2023
Q2
$15.6K Hold
13,035
﹤0.01% 2064
2023
Q1
$19.8K Sell
13,035
-656
-5% -$2.47K ﹤0.01% 1891
2022
Q4
$51.6K Hold
13,691
﹤0.01% 1453
2022
Q3
$68.2K Hold
13,691
﹤0.01% 1249
2022
Q2
$63.5K Buy
+13,691
New +$83.7K ﹤0.01% 1339

Other funds holding PTRA

Metropolitan Life Insurance Company (MetLife)'s PTRA Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 13,035 shares — an estimated $15.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PTRA in Q2 2022 and held it in 5 quarters. The position peaked at $68.2K in Q3 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 13,035 Proterra Inc. Common Stock shares in Q3 2023, an estimated $15.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Proterra Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Proterra Inc. Common Stock position peaked at $68.2K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.